Viromed Medical AG Inks Exclusive Deal with UMECO Group for Asian Market

Viromed Medical AG has announced a significant agreement with UMECO Group for the exclusive distribution of its cold plasma medical devices ViroCAP® and PulmoPlas® across ten Asian countries. The five-year deal, valued at EUR 152.5 million, grants UMECO rights in Korea, Taiwan, Thailand, Indonesia, Japan, Shanghai, the Philippines, Singapore, Malaysia, and Vietnam.

The agreement includes a USD 5 million license fee and purchase commitments totaling EUR 152.5 million through 2028. This partnership allows Viromed access to UMECO’s robust distribution network, aligning with its strategic growth in the Asian market.

ViroCAP® and PulmoPlas® are regarded as breakthroughs in dermatological and pneumological treatments, reflecting Viromed's emphasis on innovative technology in medicine and cosmetics.